Search Clinical Trials
111 matching studies
| Sponsor Condition of Interest |
|---|
|
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Temple University
COPD
Parallel-group, prospective, randomized, controlled phase III trial of home High flow
Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical
care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients
with moderate to very severe COPD at1 expand
Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at risk for moderate and severe exacerbations with a prior history of severe exacerbation requiring hospitalization within the past 6 weeks. Type: Interventional Start Date: Feb 2022 |